blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4356928

EP4356928 - NUCLEOSIDE DIPHOSPHATE OR DIPHOSPHONATE PRODRUGS, OR NUCLEOSIDE ANALOGUE DIPHOSPHATE OR DIPHOSPHONATE PRODRUGS [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  22.03.2024
Database last updated on 17.07.2024
Most recent event   Tooltip22.03.2024Publication in section I.1 EP Bulletinpublished on 24.04.2024  [2024/17]
Applicant(s)For all designated states
Universität Hamburg
Mittelweg 177
20148 Hamburg / DE
[2024/17]
Inventor(s)01 / Meier, Chris
21635 Jork / DE
02 / Jia, Xiao
20146 Hamburg / DE
 [2024/17]
Representative(s)Stüven, Ralf
RGTH Patentanwälte PartGmbB
Kirchenhang 32b
21073 Hamburg / DE
[2024/17]
Application number, filing date22202808.620.10.2022
[2024/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4356928
Date:24.04.2024
Language:EN
[2024/17]
Search report(s)(Supplementary) European search report - dispatched on:EP13.04.2023
ClassificationIPC:A61K47/54, A61P31/12
[2024/17]
CPC:
A61P31/12 (EP); A61K47/548 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/17]
Extension statesBANot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:NUKLEOSID-DIPHOSPHAT- ODER DIPHOSPHONAT-PRODRUGS ODER NUKLEOSID-ANALOG-DIPHOSPHAT- ODER DIPHOSPHONAT-PRODRUGS[2024/17]
English:NUCLEOSIDE DIPHOSPHATE OR DIPHOSPHONATE PRODRUGS, OR NUCLEOSIDE ANALOGUE DIPHOSPHATE OR DIPHOSPHONATE PRODRUGS[2024/17]
French:PROMÉDICAMENTS DE NUCLÉOSIDE DIPHOSPHATE OU DIPHOSPHONATE, OU PROMÉDICAMENTS DE NUCLÉOSIDE ANALOGUE DIPHOSPHATE OU DIPHOSPHONATE[2024/17]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDY]WO2016026493  (UNIVERSITÄT HAMBURG [DE]) [XD] 1-6,8,9,11-14 * pages 29-30; claims 4, 5, 6 * [Y] 7,10;
 [XY]  - WEINSCHENK LINA ET AL, "Nucleoside Diphosphate Prodrugs: Nonsymmetric Di PP ro-Nucleotides", JOURNAL OF MEDICINAL CHEMISTRY, US, vol. 58, no. 15, doi:10.1021/acs.jmedchem.5b00737, ISSN 0022-2623, (20150722), pages 6114 - 6130, URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00737, XP093036564 [X] 1-6,8,9,11-14 * Abstract, figure 1 * [Y] 7,10

DOI:   http://dx.doi.org/10.1021/acs.jmedchem.5b00737
 [X]  - HOSTETLER K Y ET AL, "SYNTHESIS AND ANTIRETROVIRAL ACTIVITY OF PHOSPHOLIPID ANALOGS OF AZIDOTHYMIDINE AND OTHER ANTIVIRAL NUCLEOSIDES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19900415), vol. 265, no. 11, ISSN 0021-9258, pages 6112 - 6117, XP000371928 [X] 1,9,11-14 * figure 1, page 6113, left column, 2nd and 3rd paragraph *
 [Y]  - Jia Xiao, "Membrane-Permeable Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogues: gamma-(Phosphate or Phosphonate)-Modified Nucleotide Analogues", (20200101), URL: https://ediss.sub.uni-hamburg.de/handle/ediss/8566, (20230331), XP093036542 [Y] 7,10 * pages 92-99 and scheme 31, figure 22, table 5, pages 260, structures 70a-c and 71a-d *
 [Y]  - Jia Xiao, "Membrane-Permeable Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogues: [gamma]-(Phosphate or Phosphonate)-Modified Nucleotide Analogues", (20200101), URL: https://ediss.sub.uni-hamburg.de/handle/ediss/8566, (20230331), XP093036546 [Y] 7,10 * the whole document *
by applicantWO2009129798
 WO2016026493
 WO2018100137
    - BALZARINI, P. HERDEWIJNE. DE CLERCQ, "Differential Patterns of intracellular Metabolism of 2',3'-Didehydro-2',3'-dideoxythymidine and 3'-Azido-2',3'-dideoxythymidine, two potent Anti-human Immunodeficiency Virus Compounds", J. Biol. Chem., (19890000), vol. 264, pages 6127 - 6133
    - RJ SAWCHUKZ. YANG, "Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system", Advanced Drug Delivery Reviews, (19990000), vol. 39, pages 5 - 31
    - A. POMPONI. LEFEBVREJ.-L. IMBACHS. KHAND. FARQUHAR, "Decomposition Pathways of the Mono-(Pivaloyloxymethyl) and Bis-(Pivaloyloxymethyl) Esters of Azidothymidine- 5'-Monophosphate in Cell Extract and in Tissue-Culture Medium - An Application of the Online ISRP-Cleaning HPLC Technique", Antiviral Chem. Chemother, (19940000), vol. 5, pages 91 - 98
    - I. LEFEBVREC. PERIGAUDA. POMPONA.-M. AUBERTINJ.-L. GIRARDETA. KIMG. GOSSELINJ.-L. IMBACH, "Mononucleoside Phosphotriester Derivates with S Acyl-2-thioethyl Bioreversible Phosphate-Protecting Groups: Intracellular Delivery of 3'-Azido-2',3'-dideoxythymidine-5'-monophosphate", J. Med. Chem., (19950000), vol. 38, doi:10.1021/jm00020a007, pages 3941 - 3950, XP002293734

DOI:   http://dx.doi.org/10.1021/jm00020a007
    - W. THOMSOND. NICHOLLSW. J. IRWINJ. S. AL-MUSHADANIS. FREEMANA. KARPASJ.PETRIKN. MAHMOODA. J. HAY, "Synthesis, Bioactivation and Anti-HIV Activity of the Bis(4-acyloxybenzyl) and Mono(4-acyloxybenzyl) Esters of the 5'-Monophosphate of AZT", J. Chem. Soc., Perkin Trans, (19930000), vol. 1, pages 1239 - 1245, XP009120657
    - A. ROUTLEDGEI. WALKERS. FREEMANA. HAYN. MAHMOOD, "Synthesis, Bioactivation and Anti-HIV Activity of 4-Acyloxybenzyl Bis(Nucleosid-5-yl) Phosphates", Nucl. Nucl., (19950000), vol. 14, doi:10.1080/15257779508009491, pages 1545 - 1558, XP009120656

DOI:   http://dx.doi.org/10.1080/15257779508009491
    - C. MEIER, "Cyc/oSal Phosphates as Chemical trojan Horses for the intracellular Nucleotide and Glycosylmonophosphate Delivery - Chemistry meets Biology", Eur. J. Org. Chem., (20060000), pages 1081 - 1102
    - JESSEN HJSCHULZ TBALZARINI JMEIER C, "Bioreversible protection of nucleoside diphosphates", Angew. Chem., (20080000), vol. 47, no. 45, doi:10.1002/anie.200803100, pages 8719 - 22, XP002538710

DOI:   http://dx.doi.org/10.1002/anie.200803100
    - T. GOLLNESTT. DINIS DE OLIVEIRAA. RATHI. HAUBERD. SCHOLSJ. BALZARINIC. MEIER, "Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues", Angew. Chem., (20160000), vol. 55, doi:10.1002/anie.201511808, page 5255, XP055396608

DOI:   http://dx.doi.org/10.1002/anie.201511808
    - MEIER C, "Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?", Antiviral Chem. Chemother, (20171200), vol. 25, no. 3, doi:10.1177/2040206617738656, pages 69 - 82, XP055458335

DOI:   http://dx.doi.org/10.1177/2040206617738656
    - JIA XSCHOLS DMEIER C, "Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues", J. Med. Chem., (20200709), vol. 63, no. 13, doi:10.1021/acs.jmedchem.0c00358, pages 6991 - 7007, XP055888348

DOI:   http://dx.doi.org/10.1021/acs.jmedchem.0c00358
    - JIA XSCHOLS DMEIER C, "Anti-HIV-Active Nucleoside Triphosphate Prodrugs", J. Med. Chem., (20200611), vol. 63, no. 11, pages 6003 - 6027
    - ZHAO CJIA XSCHOLS DBALZARINI JMEIER C, "γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV", ChemMedChem, (20210204), vol. 16, no. 3, pages 499 - 512
    - JIA XGANTER BMEIER C, "Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral", Annu. Rep. Med. Chem., (20210000), vol. 57, pages 1 - 47
    - C. ZHAOS. WEBERD. SCHOLSJ. BALZARINIC. MEIER, "Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase", Angew. Chem., (20200000), vol. 59, pages 22063 - 22071
    - JIA XWEBER SSCHOLS DMEIER C, J. Med. Chem., (20200000), vol. 63, no. 20, pages 11990 - 12007
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.